The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients

The immunogenicity and safety of vaccines against coronavirus disease 2019 (COVID-19) remain unknown in patients with a history of pulmonary tuberculosis (OPTB). Therefore, the safety and effectiveness of inactivated vaccines against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) were...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Lei, Xiang, Feng, Wang, Dian, Guo, Qiao, Deng, Bing, Jiang, DePeng, Ren, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970849/
https://www.ncbi.nlm.nih.gov/pubmed/36849838
http://dx.doi.org/10.1007/s10096-023-04566-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970849/
https://www.ncbi.nlm.nih.gov/pubmed/36849838
http://dx.doi.org/10.1007/s10096-023-04566-0

Ejemplares similares